IL273996A - Dosing regimens for use with pcsk9 inhibitors - Google Patents

Dosing regimens for use with pcsk9 inhibitors

Info

Publication number
IL273996A
IL273996A IL273996A IL27399620A IL273996A IL 273996 A IL273996 A IL 273996A IL 273996 A IL273996 A IL 273996A IL 27399620 A IL27399620 A IL 27399620A IL 273996 A IL273996 A IL 273996A
Authority
IL
Israel
Prior art keywords
dosing regimens
pcsk9 inhibitors
pcsk9
inhibitors
regimens
Prior art date
Application number
IL273996A
Other languages
English (en)
Hebrew (he)
Original Assignee
Regeneron Pharma
Sanofi Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/065149 external-priority patent/WO2015073494A1/en
Application filed by Regeneron Pharma, Sanofi Biotechnology filed Critical Regeneron Pharma
Publication of IL273996A publication Critical patent/IL273996A/en

Links

IL273996A 2013-11-12 2020-04-16 Dosing regimens for use with pcsk9 inhibitors IL273996A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361902857P 2013-11-12 2013-11-12
US201461955337P 2014-03-19 2014-03-19
EP14306222 2014-07-31
PCT/US2014/065149 WO2015073494A1 (en) 2013-11-12 2014-11-12 Dosing regimens for use with pcsk9 inhibitors

Publications (1)

Publication Number Publication Date
IL273996A true IL273996A (en) 2020-05-31

Family

ID=69737471

Family Applications (1)

Application Number Title Priority Date Filing Date
IL273996A IL273996A (en) 2013-11-12 2020-04-16 Dosing regimens for use with pcsk9 inhibitors

Country Status (4)

Country Link
JP (1) JP2020037566A (ja)
ES (1) ES2864350T3 (ja)
IL (1) IL273996A (ja)
TW (1) TW202017595A (ja)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3672B1 (ar) * 2008-12-15 2020-08-27 Regeneron Pharma أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).

Also Published As

Publication number Publication date
TW202017595A (zh) 2020-05-16
JP2020037566A (ja) 2020-03-12
ES2864350T3 (es) 2021-10-13

Similar Documents

Publication Publication Date Title
IL245564A0 (en) Taking regimen when using pcsk9 antagonists
IL268180A (en) Dosing regimens of anti-FOLR1 immunoconjugate
ZA201902009B (en) Anti-folr1 immunocunjugate dosing regimens
HK1219475A1 (zh) 腦啡肽酶抑制劑
EP2948458A4 (en) BTK INHIBITORS
EP2970340A4 (en) BETA-Lactamase INHIBITORS
EP2943204A4 (en) BETA-Lactamase INHIBITORS
PL2798995T3 (pl) Urządzenie dozujące
EP2948431A4 (en) BTK INHIBITORS
HK1216531A1 (zh) 新的抑制劑
GB201314578D0 (en) Bicyclic inhibitors
EP3012425A4 (en) DEVICE FOR DETERMINING THE SUCCESS OF UREA WATER
GB201305517D0 (en) Materials for use in chemical looping combustion
PL3024825T3 (pl) Imidazolokarboksyamidy i ich zastosowanie jako inhibitorów faah
IL273996A (en) Dosing regimens for use with pcsk9 inhibitors
ES1096306Y (es) Tapon para envases
GB201304599D0 (en) Dosing regimen
GB201318502D0 (en) Determining nagalase concentration
GB201311875D0 (en) Activity level device